Intravenous Immunoglobulin in Combination Therapy With Antibacterial Agents for SSI of the Lower Digestive Tract
Status:
Withdrawn
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the clinical usefulness of IVIG in combination therapy
with antibacterial agents for severe peritonitis after lower digestive tract surgery.
Phase:
N/A
Details
Lead Sponsor:
Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group